期刊文献+

EGF/PI3K信号传导调控骨桥蛋白在肝癌HepG2细胞中的表达 被引量:6

EGF/PI3K signaling pathway regulates the expression of osteopontin in liver cancer HepG2 cells
原文传递
导出
摘要 目的 检测生长因子受体激活后骨桥蛋白在肝癌细胞株HepG2中表达的变化规律 ,并探讨这一变化的信号传导途径。方法 利用RNA酶保护性分析、蛋白质印迹技术检测HepG2在表皮生长因子 (EGF)刺激前后骨桥蛋白的表达 ;并用Wortmannin特异性地阻断磷脂酰肌醇 3激酶(PI3K)信号通道 ,以观察骨桥蛋白表达的变化是否与PI3K信号传导途径有关。结果 在无血清培养条件下 ,骨桥蛋白在HepG2中少量表达 ,而EGF能诱导其表达 ,且呈剂量依赖性及时间依赖性。先用Wortmannin预处理HepG2细胞再用EGF诱导 ,能阻断骨桥蛋白的表达。结论 EGF通过PI3K信号通道诱导转移相关基因 骨桥蛋白的表达 ,提示可通过干预该途径中的某些关键基因来阻断骨桥蛋白的产生 ,从而抑制肝癌的转移。 Objective To investigate the effect of epidermal growth factor (EGF) on the expression of osteopontin (OPN) in liver cancer HepG2 cells. Methods Human liver caner cells of HepG2 line were cultured in medium without bovine serum. EGF was added. Another cells were pretreated with specific phosphatidylinositol 3 (PI3) inhibitor Wortmannin and then added with EGF. HepG2 cell were collected. RNase prote4ction assay and Western blotting were used to examine the expression of OPN in the HepG2 cells. Results HepG2 cells cultured in the bovine serum free medium expressed very low level of OPN. EGF increased the expression of OPN mRNA and protein in a dose- and time-dependent manners. Pretreatment of Wortmannin significantly reduced the EGF-induced OPN expression. Conclusion EGF increases the OPN expression, possibly through PI3 signaling pathway. It is possible to block the synthesis of OPN through manipulating several target genes, thus inhibiting the metastasis of liver cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2003年第22期1980-1983,共4页 National Medical Journal of China
关键词 表皮生长因子受体 糖蛋白类 磷脂酰肌醇类 信号传递 肝肿瘤 Receptor, epidermal growth factor Glycoproteins Phosphatidylinositols Signal transduction Liver neoplasms
  • 相关文献

参考文献13

  • 1Weber GF, Ashkar S, Cantor H, et al. Receptor -ligand interaction between CD44 and osteopontin(Eta-1). Science, 1996, 271: 509-512.
  • 2Oates AJ, Barraclough R, Rudland PS, et al. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene, 1996, 13: 97-104.
  • 3Urquidi V, Sloan D, Kawai K, et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res, 2002, 8: 61-74.
  • 4Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta, 2001, 1552: 61-85.
  • 5Liu D, Aguirre Ghiso J, Estrada Y, et al. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell, 2002, 1:405-406.
  • 6Ito Y, Takeda T, Sakon M, et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer, 2001, 84:1377-1383.
  • 7Chambers AF, Behrend EI, Wilson SM, et al. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res, 1992, 12:43-48.
  • 8Behrend EI, Craig AM, Wilson SM, et al. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res, 1994, 54: 832-837.
  • 9Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int, 2002, 52:19-24.
  • 10丁凌,郑树,曹江.大肠癌及其肝转移组织骨桥蛋白mRNA的表达[J].中华医学杂志,2002,82(14):970-973. 被引量:24

二级参考文献2

共引文献23

同被引文献59

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部